NCT03404869View on ClinicalTrials.gov

Study of ORL-1M (D-mannose) in Patients With CDG-Ib

PHASE1/PHASE2UnknownINTERVENTIONAL

Enrollment

5

Participants

Timeline

Start Date

March 31, 2015

Primary Completion Date

June 1, 2019

Study Completion Date

June 1, 2019

Conditions

CDG Ib

Interventions

DRUG

ORL-1M - D-mannose

Oral ORL-1M

Trial Locations (1)

06100

RECRUITING

Orpha Labs, Ankara

Sponsors

Lead Sponsor

All Listed Sponsors

lead

Orpha Labs

INDUSTRY

NCT03404869 - Study of ORL-1M (D-mannose) in Patients With CDG-Ib | Biotech Hunter | Biotech Hunter